| Clinical EAE after antigenic challenge | |||
| Challenge antigen doses (μg/mouse) | Incidence | Av. disease grade (range) | Av. day of onset (range) |
| 200 | 4/4 | 3.75 (3-4) | 8.25 (7-9) |
| 100 | 4/4 | 3.67 (3-4) | 7.5 (7-8) |
| 50 | 4/4 | 3.25 (3-4) | 8.25 (7-10) |
| 25 | 4/4 | 3.0 (3.0) | 8.25 (8-9) |
| 10 | 4/4 | 3.0 (3.0) | 8.76 (8-9) |
| 5 | 4/4 | 2.5 (2-3) | 9.75 (9-10) |
| 1 | 2/4 | 1.0 (1.0) | 16 (14-18) |
| 0 | 0/4 | - - | - - |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.